PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDipivefrin
Dipivefrin
Akpro, Propine (dipivefrin) is a small molecule pharmaceutical. Dipivefrin was first approved as Propine on 1982-01-01. It is used to treat open-angle glaucoma in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Dipivefrin hydrochloride
Tradename
Company
Number
Date
Products
PROPINEAllerganN-018239 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
open-angle glaucomaEFO_0004190D005902H40.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
S: Sensory organ drugs
S01: Ophthalmologicals
S01E: Antiglaucoma preparations and miotics
S01EA: Sympathomimetics in glaucoma therapy
S01EA02: Dipivefrine
HCPCS
No data
Clinical
Clinical Trials
221 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CataractD002386EFO_0001059H26.9387687
MyopiaD009216EFO_0003927H52.11131822
AstigmatismD001251EFO_0004222H52.231821
GlaucomaD005901EFO_0000516H40152614
Ocular hypertensionD009798EFO_1001069H40.05218
Labor painD0489491528
HypertensionD006973EFO_0000537I10527
AnalgesiaD0006981247
Dry eye syndromesD015352H04.122236
Retinal diseasesD012164H35.9235
Show 21 more
Indications Phases 3
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Eye diseasesD005128EFO_0003966H44134
Ear diseasesD004427EFO_1001455H93.9133
Otorhinolaryngologic diseasesD010038133
Infratentorial neoplasmsD015192C71.711
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Autonomic nervous system diseasesD001342EFO_0009532G9011
HypotensionD007022EFO_0005251I9511
Orthostatic hypotensionD007024I95.111
Nervous system diseasesD009422G00-G9911
Primary dysautonomiasD05496911
Orthostatic intoleranceD05497111
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PresbyopiaD011305H52.41313
Refractive errorsD012030HP_0000483H52.799
Intraocular lensesD00791077
AphakiaD001035H27.066
Cataract extractionD00238755
AgnosiaD000377EFO_0007136F8844
Retinal perforationsD012167EFO_100102844
Epiretinal membraneD01977344
AnesthesiaD00075833
PainD010146EFO_0003843R5233
Show 37 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDipivefrin
INNdipivefrine
Description
Dipivefrin is the dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension. It has a role as a prodrug, an adrenergic agonist, a sympathomimetic agent, an antiglaucoma drug and an ophthalmology drug. It is a member of ethanolamines and a pivalate ester. It is functionally related to an adrenaline. It is a conjugate base of a dipivefrin(1+).
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
Identifiers
PDB
CAS-ID52365-63-6
RxCUI
ChEMBL IDCHEMBL1201262
ChEBI ID4646
PubChem CID3105
DrugBankDB00449
UNII ID8Q1PVL543G (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Dipivefrin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,341 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
17 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use